Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1138 |  SRRK Scholar Rock Holding Corporation - Common Stock | 56.07 USD | -0.76% | +7.60% | +15.30% | +86.78% | 6.83 B USD | ||
| 1185 |  COGT Cogent Biosciences, Inc. - Common Stock | 36.28 USD | -1.23% | -4.12% | -9.41% | +131.53% | 6.30 B USD | ||
| 1192 |  BLTE Belite Bio Inc - American Depositary Shares | 159.15 USD | -1.19% | -2.26% | +3.12% | +145.60% | 6.26 B USD | ||
| 1199 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 95.71 USD | -0.62% | -4.45% | -16.88% | +36.48% | 6.21 B USD | ||
| 1206 |  DNTH Dianthus Therapeutics, Inc. - Common Stock | 109.70 USD | -1.26% | -4.88% | +5.64% | +351.44% | 6.14 B USD | ||
| 1207 |  TVTX Travere Therapeutics, Inc. - Common Stock | 64.15 USD | -2.37% | +2.53% | +10.70% | +122.98% | 6.05 B USD | ||
| 1210 |  ERAS Erasca, Inc. - Common Stock | 17.17 USD | -2.61% | -6.53% | -11.77% | +986.71% | 6.01 B USD | ||
| 1212 |  LQDA Liquidia Corporation - Common Stock | 68.57 USD | -0.07% | -9.43% | -20.44% | +203.41% | 6.14 B USD | ||
| 1230 |  DFTX Definium Therapeutics, Inc. - Common Shares | 42.45 USD | -5.48% | -3.63% | -2.75% | +180.94% | 5.70 B USD | ||
| 1240 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 60.35 USD | -0.69% | -2.05% | -7.93% | +47.95% | 5.84 B USD | ||
| 1251 |  PTCT PTC Therapeutics, Inc. - Common Stock | 68.20 USD | -2.32% | -4.89% | -12.14% | +34.68% | 5.69 B USD | ||
| 1260 |  CRSP CRISPR Therapeutics AG - Common Shares | 57.20 USD | -3.87% | +7.42% | +20.02% | +5.44% | 5.53 B USD | ||
| 1266 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 281.87 USD | -1.54% | -4.59% | -7.57% | +50.64% | 5.62 B USD | ||
| 1344 |  ACAD ACADIA Pharmaceuticals Inc. - Common Stock | 29.26 USD | -0.81% | +2.49% | +16.07% | +14.03% | 5.04 B USD | ||
| 1372 |  DYN Dyne Therapeutics, Inc. - Common Stock | 25.38 USD | -2.76% | -0.47% | +1.52% | +8.42% | 4.74 B USD | ||
| 1382 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 43.20 USD | -2.22% | -0.32% | +3.85% | +183.65% | 4.69 B USD | ||
| 1418 |  CELC Celcuity Inc. - Common Stock | 91.32 USD | -2.36% | -0.72% | +8.57% | +72.56% | 4.47 B USD | ||
| 1449 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 59.68 USD | -0.23% | +1.96% | +10.97% | +188.87% | 4.37 B USD | ||
| 1468 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 39.27 USD | +1.58% | +77.61% | +112.27% | +323.17% | 4.38 B USD | ||
| 1477 |  RLAY Relay Therapeutics, Inc. - Common Stock | 18.88 USD | -2.88% | -5.93% | +2.22% | +411.65% | 4.14 B USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
 ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
 OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |